Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:59:35.760Z.
Calculation as of: 2026-10-06T19:59:35.760Z.
Quote observation: 2026-10-06T19:55:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3426d5a31c39f39b03255f489736213a5d3ef01d64930d1418f7917ed6abe5c1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$995.51M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$998.69M
EV/EBIT Ratio
N/A
TTM Avg
2.12x
3Y Avg
2.12x
5Y Avg
2.12x
Market Cap
$982.46M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
EV/EBIT Ratio
5.17x
TTM Avg
6.47x
3Y Avg
6.47x
5Y Avg
6.47x
Market Cap
$1.02B
EV/EBIT Ratio
N/A
TTM Avg
59.55x
3Y Avg
59.55x
5Y Avg
78.29x
Market Cap
$971.74M
EV/EBIT Ratio
63.86x
TTM Avg
51.40x
3Y Avg
38.19x
5Y Avg
39.85x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $993.04M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $995.51M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | N/A | 2.12x | 2.12x | 2.12x |
| Immatics N.V. (IMTX)vs › | $1.01B | N/A | 40.23x | 40.23x | 40.23x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 5.17x | 6.47x | 6.47x | 6.47x |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | N/A | 59.55x | 59.55x | 78.29x |
| Pacira BioSciences, Inc. (PCRX)vs › | $971.74M | 63.86x | 51.40x | 38.19x | 39.85x |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
